Relapsing Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Relapsing Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-11Clinical Trial Results: A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis [Phase 3]
Phase III non-inferiority trial comparing subcutaneous versus intravenous ocrelizumab in relapsing and primary progressive multiple sclerosi…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis [Phase 3]
Phase 3 clinical trial comparing a proposed ocrelizumab biosimilar CYB704 with Ocrevus in relapsing multiple sclerosis to assess PK, PD, eff…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) [Phase 3]
A Phase 3 clinical trial update comparing remibrutinib to teriflunomide in relapsing multiple sclerosis, evaluating efficacy and safety, wit…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Characterizing the Use of Ofatumumab in a Real World Setting
A completed real-world observational study evaluating how ofatumumab is used to treat relapsing multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) [Phase 3]
Phase 3 clinical trial assessing the efficacy and safety of remibrutinib versus teriflunomide in relapsing multiple sclerosis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS [Phase 3]
A completed Phase 3 open-label trial comparing ofatumumab 20 mg with a first-line disease-modifying therapy in relapsing multiple sclerosis …
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS) [Phase 3]
A Phase 3 study evaluating a higher dose of ocrelizumab in adults with relapsing multiple sclerosis; the trial is not recruiting and results…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis. [Phase 3]
A Phase 3 clinical trial update evaluating the long-term safety and tolerability of tolebrutinib in participants with multiple sclerosis, in…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab [Phase 4]
A Phase 4 prospective study update examining disease activity and biomarkers in minority participants with relapsing multiple sclerosis trea…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: 9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis [Phase 3]
A Phase 3 trial evaluating the efficacy of Ofatumumab on microglial activity in patients with Relapsing Multiple Sclerosis has completed and…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2)
The MASTER-2 trial in relapsing multiple sclerosis, evaluating suboptimally controlled participants previously on oral or infusion disease-m…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab [Phase 3]
Phase 3 open-label trial evaluating the effectiveness and patient-reported outcomes of switching relapsing MS patients from dimethyl fumarat…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Study of Efficacy and Safety of Ofatumumab in Relapsing Multiple Sclerosis (RMS) Patients in China [Phase 4]
A Phase 4 study evaluating the efficacy and safety of ofatumumab in Relapsing Multiple Sclerosis patients in China has completed and results…
-
CLINICAL_TRIALS trial_result · 2025-10-23Clinical Trial Update: Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis [Phase 2]
The Phase 2 long-term safety and efficacy trial of tolebrutinib in relapsing multiple sclerosis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Study of Efficacy and Safety of Fingolimod (Gilenya) 0.5 mg in Chinese Patients With Relapsing Multiple Sclerosis (RMS) Patients [Phase 4]
Phase 4 study evaluating the efficacy and safety of fingolimod 0.5 mg in Chinese patients with relapsing multiple sclerosis; results have be…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis [Phase 3]
A Phase 3, non-inferiority trial comparing subcutaneous versus intravenous ocrelizumab in relapsing and primary progressive multiple scleros…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2) [Phase 3]
Phase 3 GEMINI 2 trial evaluating tolebrutinib (SAR442168) for relapsing forms of multiple sclerosis has completed, and results have been po…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1) [Phase 3]
Phase 3 GEMINI 1 trial of the BTK inhibitor tolebrutinib (SAR442168) for relapsing multiple sclerosis has completed enrollment, with results…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Study of Evobrutinib in Participants With RMS (evolutionRMS 1) [Phase 3]
A Phase 3 study of evobrutinib in relapsing multiple sclerosis was terminated, with results posted on ClinicalTrials.gov.
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis [Phase 3]
A long-term extension of a Phase 3 trial evaluating ponesimod 20 mg in relapsing multiple sclerosis has completed and results have been post…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Study of Evobrutinib in Participants With RMS (evolutionRMS 2) [Phase 3]
A Phase 3 study of evobrutinib in relapsing multiple sclerosis was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS) [Phase 3]
Phase 3 NOR-MS trial evaluating oral cladribine in combination with rituximab for relapsing multiple sclerosis has completed. The study inve…
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab [Phase 4]
Phase 4 clinical trial update reporting results on the immune response to SARS-CoV-2 vaccines in patients with relapsing multiple sclerosis …
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis [Phase 3]
Phase 3 single-arm trial evaluating the efficacy, safety and tolerability of ofatumumab in Relapsing Multiple Sclerosis has completed with r…
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: A Multicenter Study to Assess Response to Influenza Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab [Phase 4]
Phase 4 multicenter study results evaluating immune response to influenza vaccination in adults with relapsing multiple sclerosis treated wi…